SANOFI-AVENTIS (EPA:SAN)

BRIEF

published on 05/30/2024 at 15:06, 5 months 24 days ago

Sanofi Completes Acquisition of Inhibrx, Inc.

Acquisition Sanofi Rare Diseases Inhibrx SAR447537
PRESS RELEASE

published on 05/30/2024 at 15:01, 5 months 24 days ago

Communiqué de presse : Sanofi finalise l’acquisition d’Inhibrx, Inc.
Sanofi finalise l’acquisition d’Inhibrx, Inc. ajoutant le SAR447537 à son portefeuille pour le développement de médicaments différenciés dans les maladies rares

Acquisition Sanofi Maladies Rares Inhibrx SAR447537
PRESS RELEASE

published on 05/30/2024 at 15:01, 5 months 24 days ago

Press Release: Sanofi completes acquisition of Inhibrx, Inc.
Sanofi completes acquisition of Inhibrx, Inc., adding SAR447537 to rare disease pipeline. Former Inhibrx shareholders receive $30.00 per share in cash and one contingent value right. Inhibrx Biosciences begins trading on NASDAQ as INXB

Acquisition Nasdaq Sanofi Inhibrx SAR447537
BRIEF

published on 05/27/2024 at 07:05, 5 months 28 days ago

La FDA accorde un examen prioritaire au Sarclisa pour le traitement du myélome multiple

FDA Sanofi Myélome Multiple Sarclisa Chimiothérapie
BRIEF

published on 05/27/2024 at 07:05, 5 months 28 days ago

FDA Grants Priority Review to Sarclisa for Treatment of Multiple Myeloma

FDA Sanofi Multiple Myeloma Sarclisa Chemotherapy
PRESS RELEASE

published on 05/27/2024 at 07:00, 5 months 28 days ago

Communiqué de presse : La FDA accorde un examen prioritaire au Sarclisa pour le traitement des patients atteints d’un myélome multiple nouvellement diagnostiqué non éligibles à une transplantation
La FDA accorde l'examen prioritaire au Sarclisa pour le traitement du myélome multiple nouvellement diagnostiqué non éligibles à une transplantation. Sanofi annonce des résultats positifs de l'étude IMROZ

FDA Sanofi Myélome Multiple Sarclisa Examen Prioritaire
BRIEF

published on 05/21/2024 at 07:35, 6 months 3 days ago

Sanofi, Formation Bio, and OpenAI Announce AI Collaboration

Collaboration AI Drug Development Sanofi OpenAI Formation Bio
BRIEF

published on 05/21/2024 at 07:35, 6 months 3 days ago

Sanofi, Formation Bio et OpenAI annoncent une collaboration en matière d'IA

Collaboration Développement De Médicaments IA Sanofi OpenAI Biographie De La Formation
PRESS RELEASE

published on 05/21/2024 at 07:30, 6 months 3 days ago

Press Release: Sanofi, Formation Bio and OpenAI announce first-in-class AI collaboration
Sanofi, Formation Bio, and OpenAI collaborate to accelerate drug development with AI-powered software. The partnership aims to bring new medicines more efficiently

Collaboration Drug Development Sanofi OpenAI Formation Bio
PRESS RELEASE

published on 05/21/2024 at 07:30, 6 months 3 days ago

Communiqué de presse : Sanofi, Formation Bio et OpenAI annoncent une coopération de première classe autour de l’IA
Sanofi, Formation Bio et OpenAI annoncent une coopération pour développer des logiciels alimentés par l'IA afin d'accélérer le développement de médicaments. Première collaboration de ce genre dans les industries pharmaceutiques et des sciences de la vie

IA Sanofi Développement De Médicaments OpenAI Formation Bio

Published on 11/22/2024 at 23:55, 1 day 12 hours ago

Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 1 day 12 hours ago

Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 1 day 13 hours ago

Kidoz Inc. Announces Results of 2024 AGM
Published on 11/22/2024 at 23:05, 1 day 13 hours ago

Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 1 day 13 hours ago

Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.

View all ACCESSWIRE

Published on 11/22/2024 at 18:14, 1 day 18 hours ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 18:00, 1 day 18 hours ago

Holding(s) in Company
Published on 11/22/2024 at 17:53, 1 day 18 hours ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 1 day 19 hours ago

EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 1 day 20 hours ago

Proposed cancellation of admission to trading

View all EQS

Published on 11/22/2024 at 17:45, 1 day 18 hours ago

IMMERSION : RFA 2023/2024
Published on 11/22/2024 at 16:15, 1 day 20 hours ago

NRJ GROUP - Le Conseil d'Etat rejette le recours de NRJ 12 et NRJ GROUP
Published on 11/22/2024 at 14:35, 1 day 21 hours ago

Communiqué de presse Thales
Published on 11/22/2024 at 14:35, 1 day 21 hours ago

Thales Press release
Published on 11/21/2024 at 06:58, 3 days 5 hours ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio

View all LES ECHOS COMFI WIRE

News